Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venexia M Walker

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
JAMA Psychiatry|December 18, 2024
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?-ReplyVenexia M Walker, Praveetha Patalay, Jonathan A C Sterne
Annual Review of Biomedical Data Science|April 1, 2022
Phenotypic Causal Inference Using Genome-Wide Association Study Data: Mendelian Randomization and BeyondVenexia M Walker, Jie Zheng, Tom R Gaunt, et al.
Scientific Reports|January 21, 2022
Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriersEmma L Anderson, Dylan M Williams, Venexia M Walker, et al.
International Journal of Epidemiology|July 24, 2019
Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization studyVenexia M Walker, Patrick G Kehoe, Richard M Martin, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2020
Comparison of Antihypertensive Drug Classes for Dementia PreventionVenexia M Walker, Neil M Davies, Richard M Martin, et al.
International Journal of Epidemiology|October 18, 2017
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunitiesVenexia M Walker, George Davey Smith, Neil M Davies, et al.
Alzheimer'S Research & Therapy|May 31, 2018
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research DatalinkVenexia M Walker, Neil M Davies, Patrick G Kehoe, et al.
International Journal of Epidemiology|June 3, 2017
Power calculator for instrumental variable analysis in pharmacoepidemiologyVenexia M Walker, Neil M Davies, Frank Windmeijer, et al.
International Journal of Epidemiology|November 26, 2019
Comparison with randomized controlled trials as a strategy for evaluating instruments in Mendelian randomizationDipender Gill, Venexia M Walker, Richard M Martin, et al.
International Journal of Epidemiology|May 2, 2020
Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancerJames Yarmolinsky, Caroline J Bull, Venexia M Walker, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
JAMA Psychiatry|December 18, 2024
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?-ReplyVenexia M Walker, Praveetha Patalay, Jonathan A C Sterne
Annual Review of Biomedical Data Science|April 1, 2022
Phenotypic Causal Inference Using Genome-Wide Association Study Data: Mendelian Randomization and BeyondVenexia M Walker, Jie Zheng, Tom R Gaunt, et al.
Scientific Reports|January 21, 2022
Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriersEmma L Anderson, Dylan M Williams, Venexia M Walker, et al.
International Journal of Epidemiology|July 24, 2019
Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization studyVenexia M Walker, Patrick G Kehoe, Richard M Martin, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2020
Comparison of Antihypertensive Drug Classes for Dementia PreventionVenexia M Walker, Neil M Davies, Richard M Martin, et al.
International Journal of Epidemiology|October 18, 2017
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunitiesVenexia M Walker, George Davey Smith, Neil M Davies, et al.
Alzheimer'S Research & Therapy|May 31, 2018
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research DatalinkVenexia M Walker, Neil M Davies, Patrick G Kehoe, et al.
International Journal of Epidemiology|June 3, 2017
Power calculator for instrumental variable analysis in pharmacoepidemiologyVenexia M Walker, Neil M Davies, Frank Windmeijer, et al.
International Journal of Epidemiology|November 26, 2019
Comparison with randomized controlled trials as a strategy for evaluating instruments in Mendelian randomizationDipender Gill, Venexia M Walker, Richard M Martin, et al.
International Journal of Epidemiology|May 2, 2020
Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancerJames Yarmolinsky, Caroline J Bull, Venexia M Walker, et al.
Pageof 3